Semax: Synthetic ACTH(4-10) Fragment — Neurological Research
A heptapeptide (MEHFPGP) studied in preclinical neurological research models in relation to BDNF and monoamine signalling.
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP) based on the ACTH(4-10) fragment, modified with a C-terminal Pro-Gly-Pro to improve stability. It is studied as a water-soluble research peptide.
Structure and identity
The Pro-Gly-Pro extension reduces enzymatic degradation relative to the native ACTH fragment. Semax is supplied as a lyophilised powder for laboratory reconstitution.
What the research literature examines
In-vitro and animal studies have investigated Semax in relation to BDNF expression and dopaminergic and serotonergic signalling in model systems. This work is exploratory. Vivera Labs makes no claims regarding effects in humans; the compound is supplied strictly for in-vitro laboratory research.
Why purity matters for this peptide
As with all neuropeptide research tools, assay validity depends on sequence fidelity. Each batch is independently HPLC-tested with a Certificate of Analysis available on request.
- Identity confirmed by mass spectrometry
- Purity quantified by HPLC
- Batch-specific documentation
- Cold-chain stored
The references below link to peer-reviewed sources for further reading.
Sources
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.